N
Name | Dosage form | ATC code |
---|---|---|
Acetylsalicylic acid Acetylsalicylic acid 500 mg № 10 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg № 10 | N02BA01 |
Alzhmerat Alzhmerat 250 mg/ml, 4 ml № 5, № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
250 mg/ml, 4 ml № 5, № 10, № 100 | N07AX02 |
Alzhmerat Alzhmerat 600 mg/7 ml № 10 Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
600 mg/7 ml № 10 | N07A X02 |
Amitriptylline Amitriptylline 25 mg № 50, № 1000 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
25 mg № 50, № 1000 | N06AA09 |
Analgin Analgin 500 mg/ml, 2 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg/ml, 2 ml № 10 | N02BB02 |
Analgin for children Analgin for children 0,1 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,1 g № 10 | N02BB02 |
Analgin for children Analgin for children 0,25 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,25 g № 10 | N02BB02 |
Azaleptol Azaleptol 100 mg №50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
100 mg №50 | N05AH02 |
Azaleptol Azaleptol 25 mg № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
25 mg № 50 | N05AH02 |
Barviton Barviton 5 mg/ml, 2 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml, 2 ml № 10 | N06BX18 |
Carbamazepine Carbamazepine 200 mg №20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg №20 | N03AF01 |
Carbamazepine Carbamazepine 200 mg № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg № 50 | N03AF01 |
Cilityn Cilityn 250 mg/ml, 4 ml № 5, № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
250 mg/ml, 4 ml № 5, № 10, № 100 | N06BX06 |
Cinnarizine Cinnarizine 0,025 g № 25, № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,025 g № 25, № 50 | N07CA02 |
Cylityne Cylityne 100 mg, 30 ml Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
100 mg, 30 ml | N06BX06 |
Epigaba Epigaba 300 mg №100 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
300 mg №100 | N03AX12 |
Epigaba Epigaba 300 mg № 20 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
300 mg № 20 | N03AX12 |
Ipidacord Ipidacord 15 mg/ml 1 ml №10 Solution for injections Pharmacotherapeutic group Agents affecting the nervous system |
15 mg/ml 1 ml №10 | N07АА |
Ipidacord Ipidacord 5 mg/ml 1 ml №10, №100 Solution for injections Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml 1 ml №10, №100 | N07АА |
Leknizine Leknizine 0,025 g № 10, № 50 Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,025 g № 10, № 50 | N07CA02 |
Lektil 200 | 200 mg №50 | N03A F01 |
Lidocaine Lidocaine 20 mg/ml, 2 ml in ampoules № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
20 mg/ml, 2 ml in ampoules № 10 | N01BB02 |
Lidocaine Lidocaine 10 mg/ml, 3,5 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml, 3,5 ml № 10 | N01BВ02 |
Nalbuphine Nalbuphine 10 mg/ml 2 ml №5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml 2 ml №5 | N02AF02 |
Nalbuphine Nalbuphine 10 mg/ml 1 ml №10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml 1 ml №10 | N02AF02 |
Novocaine Novocaine 5 mg/ml, 5 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml, 5 ml № 10 | N01BA02 |
Paracetamol Paracetamol 500 mg №10, №20, №50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg №10, №20, №50 | N02B E01 |
Piracetam Piracetam 200 mg/mg, 5 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg/mg, 5 ml № 10 | N06BX03 |
Pregalon 150 | 150 mg №21 | N03A X16 |
Pregalon 150 | 150 мг №14 | N03A X16 |
Pregalon 300 | 300 mg №21 | N03A X16 |
Pregalon 300 | 300 мг №14 | N03A X16 |
Pregalon 75 | 75 mg №21 | N03A X16 |
Pregalon 75 | 75 мг №14 | N03A X16 |
Tet 36.6 RAPID with acacia flavour Tet 36.6 RAPID with acacia flavour 23 g № 5, № 10 Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
Tet 36.6 RAPID with lemon flavour Tet 36.6 RAPID with lemon flavour 23 g № 5, № 10 Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
Tеt 36.6 MAXI with lemon flavour Tеt 36.6 MAXI with lemon flavour 23 g № 5, № 10 Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
Tеt 36.6 MAXI with raspberry flavour Tеt 36.6 MAXI with raspberry flavour 23 g № 5, № 10 Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BE51 |
Tеt 36.6 with acacia flavour Tеt 36.6 with acacia flavour 13,1 g № 5, № 10 Powder for oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
13,1 g № 5, № 10 | N02BE51 |
Venocor Venocor 50 mg/ml 2 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
50 mg/ml 2 ml № 10 | N07XX |
Venocor Venocor 50 mg/ml, 5 ml № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
50 mg/ml, 5 ml № 5 | N07XX |
Vinpocetin Vinpocetin 0,005 g № 30, № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,005 g № 30, № 50 | N06BX18 |